PortfoliosLab logoPortfoliosLab logo
ZSTK vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ZSTK vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ZeroStack Corp. (ZSTK) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ZSTK achieves a -64.22% return, which is significantly lower than NVO's 0.65% return.


ZSTK

1D
-10.04%
1M
-50.88%
6M
-69.25%
YTD
-64.22%
1Y
-91.62%
3Y*
-72.82%
5Y*
-75.81%
10Y*

NVO

1D
1.23%
1M
12.76%
6M
-12.92%
YTD
0.65%
1Y
-24.87%
3Y*
-11.12%
5Y*
4.91%
10Y*
8.17%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ZSTK vs. NVO - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ZSTK
ZeroStack Corp.
-64.22%-84.42%-23.70%-70.34%-87.21%-67.64%
NVO
Novo Nordisk A/S
0.65%-39.22%-15.93%54.84%22.66%47.63%

Correlation

The correlation between ZSTK and NVO is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.10

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since May 11, 2021

0.10

Fundamentals

Market Cap

ZSTK:

$2.34M

NVO:

$219.88B

EPS

ZSTK:

-$223.62

NVO:

DKK 27.42

PS Ratio

ZSTK:

0.05

NVO:

4.38

Total Revenue (TTM)

ZSTK:

$23.89M

NVO:

DKK 327.80B

Gross Profit (TTM)

ZSTK:

-$7.71M

NVO:

DKK 268.30B

EBITDA (TTM)

ZSTK:

-$9.88M

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ZSTK vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ZSTK
ZSTK Risk / Return Rank: 99
Overall Rank
ZSTK Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
ZSTK Sortino Ratio Rank: 77
Sortino Ratio Rank
ZSTK Omega Ratio Rank: 88
Omega Ratio Rank
ZSTK Calmar Ratio Rank: 22
Calmar Ratio Rank
ZSTK Martin Ratio Rank: 1111
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 2424
Overall Rank
NVO Sharpe Ratio Rank: 2121
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 2424
Sortino Ratio Rank
NVO Omega Ratio Rank: 2222
Omega Ratio Rank
NVO Calmar Ratio Rank: 2525
Calmar Ratio Rank
NVO Martin Ratio Rank: 2828
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ZSTK vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ZeroStack Corp. (ZSTK) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ZSTKNVODifference
Sharpe ratioReturn per unit of total volatility

-0.10

Sortino ratioReturn per unit of downside risk

-1.07

Omega ratioGain probability vs. loss probability

0.82

0.94

-0.11

Calmar ratioReturn relative to maximum drawdown

-0.98

-0.55

-0.43

Martin ratioReturn relative to average drawdown

-1.34

-0.86

-0.48

ZSTK vs. NVO - Sharpe Ratio Comparison

The current ZSTK Sharpe Ratio is -0.63, which is comparable to the NVO Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of ZSTK and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ZSTK vs. NVO - Drawdown Comparison

The maximum ZSTK drawdown since its inception was -99.98%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for ZSTK and NVO.


Loading charts...

Drawdown Indicators


ZSTKNVODifference

Max Drawdown

Largest peak-to-trough decline

-99.98%

-74.70%

-25.28%

Max Drawdown (1Y)

Largest decline over 1 year

-93.32%

-49.17%

-44.15%

Max Drawdown (3Y)

Largest decline over 3 years

-98.50%

-74.70%

-23.80%

Max Drawdown (5Y)

Largest decline over 5 years

-99.98%

-74.70%

-25.28%

Max Drawdown (10Y)

Largest decline over 10 years

-74.70%

Current Drawdown

Current decline from peak

-99.98%

-64.05%

-35.93%

Average Drawdown

Average peak-to-trough decline

-92.56%

-17.86%

-74.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

68.59%

31.50%

+37.09%

Volatility

ZSTK vs. NVO - Volatility Comparison

ZeroStack Corp. (ZSTK) has a higher volatility of 32.63% compared to Novo Nordisk A/S (NVO) at 8.69%. This indicates that ZSTK's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ZSTKNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

32.63%

8.69%

+23.94%

Volatility (6M)

Calculated over the trailing 6-month period

110.07%

37.47%

+72.60%

Volatility (1Y)

Calculated over the trailing 1-year period

146.89%

51.76%

+95.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

138.16%

38.52%

+99.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

137.06%

32.59%

+104.47%

Dividends

ZSTK vs. NVO - Dividend Comparison

ZSTK has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.64%.


PositionTTM20252024202320222021202020192018201720162015
NVO
Novo Nordisk A/S
3.64%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%
ZSTK
ZeroStack Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ZSTK vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between ZeroStack Corp. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober20260
96.82B
(ZSTK) Total Revenue
(NVO) Total Revenue
Please note, different currencies. ZSTK values in USD, NVO values in DKK

Frequently Asked Questions


ZSTK and NVO have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ZSTK has higher volatility (32.63%) compared to NVO (8.69%). In terms of maximum drawdown, ZSTK dropped -99.98% vs NVO's -74.70%.

NVO currently has the higher Sharpe Ratio (-0.53 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ZSTK and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer